Cardiovascular effects of a newly synthesized cardiotonic agent (TA-064) on normal and diseased hearts
- 1 March 1983
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 51 (5), 802-810
- https://doi.org/10.1016/s0002-9149(83)80137-4
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- Acute effects of oral pirbuterol on myocardial oxygen metabolism and systemic hemodynamics in chronic congestive heart failure.Circulation, 1981
- Hemodynamic effects of oral pirbuterol in chronic severe congestive heart failure.Circulation, 1981
- Long-Term Vasodilator Therapy with Trimazosin in Chronic Cardiac FailureNew England Journal of Medicine, 1980
- Oral amrinone in refractory congestive heart failureThe American Journal of Cardiology, 1980
- Long-term therapy of heart failure with prazosin: A randomized double blind trialThe American Journal of Cardiology, 1980
- Haemodynamic effects of prenalterol in patients with coronary heart disease.Heart, 1980
- Salbutamol in treatment of heart failure.Heart, 1980
- Treatment of Chronic Congestive Heart Failure with Captopril, an Oral Inhibitor of Angiotensin-Converting EnzymeNew England Journal of Medicine, 1979
- Long-term outpatient vasodilator therapy of congestive heart failureAmerican Journal Of Medicine, 1978
- Usefulness of long-acting nitrates in cardiovascular diseaseAmerican Journal Of Medicine, 1978